CHE logo

CHEChemed Corp.

$420.56
$0.31
(0.07%)
Today
Updated: 01:58 PM EDT
EarningsJul 28
Mkt Cap$5.59B
Vol60,676.00
45

Neutral Sentiment

How do you feel about CHE?

News
all
press releases
AVAH or CHE: Which Is the Better Value Stock Right Now?
AVAH vs. CHE: Which Stock Is the Better Value Option?
Zacks
News Placeholder
More News
News Placeholder
AVAH vs. CHE: Which Stock Is the Better Value Option?
AVAH vs. CHE: Which Stock Is the Better Value Option?
Zacks
News Placeholder
Sadness This Mother's Day? VITAS Healthcare Launches Free, Nationwide Mother's Day Grief Helpline
Sadness This Mother's Day? VITAS Healthcare Launches Free, Nationwide Mother's Day Grief Helpline Sadness This Mother's Day? VITAS Healthcare Launches Free, Nationwide Mother's Day Grief Helpline PR...
PR Newswire
News Placeholder
Van Berkom & Associates Inc. Acquires 4,056 Shares of Chemed Corporation $CHE
Van Berkom & Associates Inc. boosted its holdings in Chemed Corporation (NYSE:CHE - Free Report) by 2.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 174,869 shares of the company's stock after acquiring an...
MarketBeat
News Placeholder
Insider Selling: Chemed (NYSE:CHE) CEO Sells 2,000 Shares of Stock
Chemed Corporation (NYSE:CHE - Get Free Report) CEO Kevin Mcnamara sold 2,000 shares of the firm's stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive...
MarketBeat
News Placeholder
Chemed Corporation $CHE Position Trimmed by Vanguard Group Inc.
Vanguard Group Inc. decreased its holdings in Chemed Corporation (NYSE:CHE - Free Report) by 4.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,472,254 shares of the company's stock after selling 66,233 shares during the quarter. Vangu...
MarketBeat
News Placeholder
Chemed Q1 Earnings Call Highlights
Chemed (NYSE:CHE) executives highlighted stronger-than-expected first-quarter performance at its VITAS hospice business and early signs of improvement at Roto-Rooter, while also raising full-year guidance for 2026 based on VITAS momentum and first-quarter share repurchases. VITAS exceeded expectati...
MarketBeat
News Placeholder
CHE Stock Up Following Q1 Earnings & Revenue Beat, Margins Down
Chemed stock jumps after Q1 earnings and revenues beat estimates despite margin contraction and mixed segment performance across VITAS and Roto-Rooter.
Zacks
News Placeholder
Impax Asset Management Group plc Trims Position in Chemed Corporation $CHE
Impax Asset Management Group plc decreased its position in shares of Chemed Corporation (NYSE:CHE - Free Report) by 3.5% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 244,242 shares of the company's stock after selling 8,940 shares during the period. I...
MarketBeat
News Placeholder
Full Transcript: Chemed Q1 2026 Earnings Call
read more...
Benzinga
<
1
2
...
>

Advertisement|Remove ads.